Dacarbazine, BCNU, cisplatin and tamoxifen (DBCT) v. dacarbazine and interferon (D/I) in advanced melanoma: interim results of a randomised phase III study

M Middleton, P Lorigan, J Owen, S Lee, D Yip, J Davies, P Harper, N Thatcher

Research output: Contribution to journalArticlepeer-review

Abstract

34th Annual Meeting of the American Society of Clinical Oncology; 16‐19 May 1998; Los Angeles, California, USA
Original languageEnglish
Pages (from-to)508a, Abstract 1958
JournalProceedings of the american society of clinical oncology
Volume17 CC -
Publication statusPublished - 1998

Fingerprint

Dive into the research topics of 'Dacarbazine, BCNU, cisplatin and tamoxifen (DBCT) v. dacarbazine and interferon (D/I) in advanced melanoma: interim results of a randomised phase III study'. Together they form a unique fingerprint.

Cite this